James F. Oliviero III, Chief Financial Officer at KERYX BIOPHARMACEUTICALS INC (KERX), sold 109,500 shares at $12.64 ($1.4M) on 2013-12-30, disclosed to the SEC on 2013-12-31.
Open-market sale of $1.4M KERX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.68 | 30,000 | $380K | 27.5% |
| 2 | $12.62 | 49,500 | $625K | 45.1% |
| 3 | $12.64 | 30,000 | $379K | 27.4% |
| Total | $12.64 avg | 109,500 | $1.4M | 100% |
| Filing → |
| CKPT | SELL | 2024-12-20 | $6.1M | — | Filing → |
| CKPT | SELL | 2024-06-28 | $101K | — | Filing → |
| CKPT | SELL | 2024-03-01 | $12K | — | Filing → |